Markets
MRK

Health Care Sector Update for 02/03/2016: TRIL, MRK

Top Health-care stocks:

JNJ: +0.4%

PFE: +0.2%

ABT: flat

MRK: -0.2%

AMGN: flat

Health-care shares were mixed in pre-market trade on Wednesday.

In health-care stocks news, Trillium Therapeutics Inc. ( TRIL ), a clinical stage immuno-oncology company, has initiated dosing in its Phase 1 clinical trial of anti-tumor treatment TTI-621.

Shares in the company were flat at $7.93 pre-bell. The company has traded between $7.16 and $29.92 over the past 52 weeks.

And Merck & Company ( MRK ) said on Wednesday that its pharmaceutical sales declined amid news reports saying the company is considering exiting a joint venture with Sanofi ( SNY ).

Shares in the company were 1.2% lower at $49.79 pre-bell. The company has traded between $45.69 and $61.70 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRK TRIL SNY

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More